ReviewJournal of thoracic disease2018
Surgical embolectomy for acute massive pulmonary embolism: state of the art.
Review in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 42 citations in OpenAlex.
- Surgical Pulmonary Embolectomy Versus Systemic Thrombolysis in High-Risk Pulmonary Embolism: A Retrospective Single-Center Analysis.Journal of clinical medicine · 2025Article
- A Prospective Cross-Sectional Cohort Study on Factors Associations With Right Heart Thrombi and Pulmonary Embolism.Health science reports · 2025Article
- Severe Traumatic Brain Injury and Pulmonary Embolism: Risks, Prevention, Diagnosis and Management.Journal of clinical medicine · 2024Review
- Article
- Simple and secure thrombectomy without circulatory arrest for acute pulmonary embolism.Journal of cardiothoracic surgery · 2024Article
- Incidence and outcomes of surgical pulmonary embolectomy in the UK.The British journal of surgery · 2024Article
- Surgical pulmonary embolectomy: state of the art.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2023Review
- Surgical Management of Massive Pulmonary Embolism Presenting with Cardiopulmonary Arrest: How Far Is Too Far?Brazilian journal of cardiovascular surgery · 2023Article
- Dilemma of Thrombolysis in a patient with high-risk Pulmonary Embolism with severe Thrombocytopenia: A case report.Qatar medical journal · 2023Article
- Evolving Management Trends and Outcomes in Catheter Management of Acute Pulmonary Embolism.Journal of cardiothoracic and vascular anesthesia · 2022Review
- Flexible fibre optic bronchoscopy as angioscope to ascertain completeness of pulmonary embolectomy: surgery for pulmonary embolism-how I do it.Indian journal of thoracic and cardiovascular surgery · 2022Article
- Catheter-Directed Thrombectomy: An Alternative in Massive Pulmonary Embolism.Case reports in cardiology · 2022Article
- Advanced management of intermediate-high risk pulmonary embolism.Critical care (London, England) · 2021Review
- Successful pulmonary embolectomy with central extra-corporeal membranous oxygenation for acute pulmonary thromboembolism.Surgery today · 2020Article
- Future perspectives in catheter-based treatment of pulmonary embolism.European heart journal supplements : journal of the European Society of Cardiology · 2019Article
- Anesthetic management of chronic thromboembolic pulmonary hypertension for surgical pulmonary thromboendarterectomy: A narrative review.Journal of anaesthesiology, clinical pharmacologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death caused by right ventricular (RV) failure and the consequent cardiogenic shock. Despite the fact thrombolysis is often administrated to critical patients to increase pulmonary perfusion and to reduce RV afterload, surgical treatment represents another valid option in case of failure or contraindications to thrombolytic therapy. Correct risk stratification and multidisciplinary proactive teams are critical factors to dramatically decrease the mortality of this global health burden. In fact, the worldwide incidence of PE is 60-70 per 100,000, with a mortality ranging from 1% for small PE to 65% for massive PE. This review provides an overview of the diagnosis and management of this highly lethal pathology, with a focus on the surgical approaches at the state of the art.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.